Sight Sciences/$SGHT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sight Sciences
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Ticker
$SGHT
Sector
Primary listing
Employees
186
Headquarters
Website
Sight Sciences Metrics
BasicAdvanced
$210M
-
-$0.74
2.43
-
Price and volume
Market cap
$210M
Beta
2.43
52-week high
$9.24
52-week low
$2.03
Average daily volume
343K
Financial strength
Current ratio
10.223
Quick ratio
9.224
Long term debt to equity
63.026
Total debt to equity
63.769
Interest coverage (TTM)
-6.67%
Profitability
EBITDA (TTM)
-33.812
Gross margin (TTM)
86.17%
Net profit margin (TTM)
-49.67%
Operating margin (TTM)
-44.34%
Effective tax rate (TTM)
-0.03%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
-16.61%
Return on equity (TTM)
-50.74%
Valuation
Price to revenue (TTM)
2.622
Price to book
3.25
Price to tangible book (TTM)
3.25
Price to free cash flow (TTM)
-6.78
Free cash flow yield (TTM)
-14.75%
Free cash flow per share (TTM)
-0.574
Growth
Revenue change (TTM)
-3.13%
Earnings per share change (TTM)
-28.28%
3-year revenue growth (CAGR)
2.74%
3-year earnings per share growth (CAGR)
-25.78%
What the Analysts think about Sight Sciences
Analyst ratings (Buy, Hold, Sell) for Sight Sciences stock.
Sight Sciences Financial Performance
Revenues and expenses
Sight Sciences Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sight Sciences stock?
Sight Sciences (SGHT) has a market cap of $210M as of March 18, 2026.
What is the P/E ratio for Sight Sciences stock?
The price to earnings (P/E) ratio for Sight Sciences (SGHT) stock is 0 as of March 18, 2026.
Does Sight Sciences stock pay dividends?
No, Sight Sciences (SGHT) stock does not pay dividends to its shareholders as of March 18, 2026.
When is the next Sight Sciences dividend payment date?
Sight Sciences (SGHT) stock does not pay dividends to its shareholders.
What is the beta indicator for Sight Sciences?
Sight Sciences (SGHT) has a beta rating of 2.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.